4//SEC Filing
CORBETT JAMES 4
Accession 0001318310-06-000007
CIK 0001318310other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 6:32 PM ET
Size
24.3 KB
Accession
0001318310-06-000007
Insider Transaction Report
Form 4
ev3 Inc.b#3bbbbb
CORBETT JAMES
Pres., CEO & Director
Transactions
- Award
Stock Option
2006-01-06+4,763→ 4,763 totalExercise: $9.14Exp: 2012-06-04→ Common Stock (4,763 underlying) - Award
Stock Option
2006-01-06+1,905→ 1,905 totalExercise: $6.47Exp: 2013-05-22→ Common Stock (1,905 underlying) - Award
Common Stock
2006-01-06+3,572→ 129,793 total - Award
Stock Option
2006-01-06+7,620→ 7,620 totalExercise: $13.23Exp: 2012-01-02→ Common Stock (7,620 underlying) - Award
Stock Option
2006-01-06+23,814→ 23,814 totalExercise: $14.70Exp: 2012-01-14→ Common Stock (23,814 underlying)
Footnotes (8)
- [F1]Received in exchange for 3,572 shares of Micro Therapeutics, Inc. common stock in connection with the merger between Micro Therapeutics, Inc. and a wholly-owned subsidiary of the issuer (the "Merger"). On the effective date of the Merger, the closing price of Micro Therapeutics, Inc. common stock was $6.64 per share, and the closing price of ev3, Inc. common stock was $14.00 per share. The issuer's board of directors approved all issuances to Reporting Person that are subject of this report.
- [F2]Includes 100,000 shares issued 12/29/05 bunder the issuer's Amended and Restated 2005 2005 Stock Incentive Plan. Such shares vest over time and are subject to forfeiture until vested.
- [F3]Received in the Merger in exchange for an option to purchase 16,000 shares of Micro Therapeutics, Inc. common stock for $6.30 per share. Vesting continued as originally set and issuer options are fully vested.
- [F4]Received in the Merger in exchange for an option to purchase 50,000 shares of Micro Therapeutics, Inc. common stock for $7.00 per share. Vesting continued as originally set and issuer options are fully vested.
- [F5]Received in the Merger in exchange for an option to purchase 10,000 shares of Micro Therapeutics, Inc. common stock for $4.35 per share. Vesting continued as originally set and issuer options are fully vested.
- [F6]Received in the Merger in exchange for an option to purchase 4,000 shares of Micro Therapeutics, Inc. common stock for $3.08 per share, which provided for vesting in the amount of 25% on May 22, 2003, with the remaining vesting in three equal annual installments thereafter. Vesting continues as originally scheduled.
- [F7]Received in the Merger in exchange for an option to purchase 4,000 shares of Micro Therapeutics, Inc. common stock for $4.17 per share, which provided for vesting in the amount of 25% on May 22, 2004, with the remaining vesting in three equal annual installments thereafter. Vesting continues as originally scheduled.
- [F8]Received in the Merger in exchange for an option to purchase 4,000 shares of Micro Therapeutics, Inc. common stock for $4.00 per share, which provided for vesting in the amount of 25% on May 26, 2004, with the remaining vesting in three equal annual installments thereafter. Vesting continues as originally scheduled.
Issuer
ev3 Inc.
CIK 0001318310
Entity typeother
Related Parties
1- filerCIK 0001238620
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 6:32 PM ET
- Size
- 24.3 KB